🔗 Share this article

Given that America undertakes historic revisions to its vaccine schedules, a particular individual has emerged somewhat surprisingly: Dr. Tracy Beth Høeg, an American of Danish descent sports medicine doctor and public health researcher who rose to prominence by casting doubt on COVID-19 vaccinations throughout the global health crisis and has zeroed in on possible fatalities after Covid immunization in her recent tenure at the US Food and Drug Administration (FDA).

Proposed Shifts to Pediatric Immunization Schedule

Health officials had intended to reveal radical changes to the childhood vaccine schedule recently, bringing the US with the Danish vaccine program, sources say – a major change that would place the US at odds with much of the international standard with little proof for improved outcomes. The announcement has been postponed until the new year.

Instead of the director of the vaccine center, Tracy Beth Høeg is set to speak at the event. She was newly appointed temporary leader of the FDA’s drug evaluation center, the fifth person to run the office this calendar year.

A New Direction at the Regulatory Body

The acting appointment may indicate a strengthened alliance between the pharmaceutical and biologics divisions as Høeg and Dr. Prasad consolidate power at the agency – and it points to a increased emphasis upon reevaluating already-approved vaccines at the FDA.

The new acting director has often pushed for discontinuing some childhood immunization guidelines in the US so as to align more similar to the Danish model, a nation with comprehensive healthcare and a citizenry about the population of the state of Wisconsin.

In her initial comments, she has continued to focus on immunizations – typically the domain of Prasad, director of the FDA’s vaccine center – instead of drug regulation.

Questions Over Background

The appointee has no apparent experience in medication creation, regulation or leadership, which has been typical for former heads of the CBER. She has worked at the FDA as a top consultant to the FDA chief and CBER since earlier this year.

“It seems she lacks to have the requisite experience” for running the CDER, remarked a neurologist and psychiatrist. “She lacks experience running a clinical trial. She is not versed in managing a sizeable institution. She is not an expert in drug approvals.”

Former commissioners of CBER would “understand regulatory frameworks and the underlying principles of medication creation”, noted Dr. Janet Woodcock. “Clearly, she lacks the kind of background that former directors who led CBER have had.”

The drug center has an immense portfolio at the agency, she stated.

“The public just zeroes in on the new drug program, but the generic program approves thousands of generic drugs. There’s a biosimilars program, OTC medication office and so forth, and each of these have to be supervised,” Woodcock said. “The responsibility you overlook, that is precisely what that I always told people is going to bite you.”

There is also, a major management element to the role, which oversees over 5,000 personnel. “It’s a massive leadership role, if you do it right,” the former official added.

Official Statement and Controversial Initiatives

In response to concerns about Høeg’s qualifications and whether this appointment signifies more teamwork among agency officials on immunizations, a representative said that the “questions rely on inaccurate presumptions”.

“Her experience matches the functions of her position,” the official explained, citing the time Høeg spent counseling the FDA commissioner on “drug safety and approval science, including predictive safety algorithms and shot safety tracking”.

As acting director, Dr. Høeg assumes responsibility for the agency head's recently launched expedited review system, a disputed one-day drug-approval program that apparently worried her predecessors. “By what process are these medications being selected for this fast-track system? Who makes the calls?” Dr. Howard said. “There’s a lot of lack of transparency happening at the agency right now.”

Overall, he stated, “the agency appears to be shifting towards more relaxed rules of most medications, except for vaccines.”

Documented Past Work on Immunizations

Regarding vaccines, Høeg has a more documented, if concerning, track record, some experts said. She authored a analysis using unconfirmed crowd-sourced reports to assess the frequency of myocarditis following Covid immunization. She consulted for the state of Florida top health official Joseph Ladapo, who allegedly have altered data to suggest Covid vaccines are more dangerous than they are.

Included in her “wish list” for the current federal leadership encompassed altering guidelines for novel immunizations and halting “non-essential” vaccines, she remarked following the vote on a audio program. At the agency, Dr. Høeg has reportedly proposed barring teenage boys from obtaining Covid vaccinations.

“She is an complete true believer who starts off with her preconceived notions and works backwards to accommodate the evidence in a highly misleading, dishonest fashion,” Howard said.

Consolidating Power and a “Campaign of Retribution”

Høeg joined fellow skeptics, {like|